Last €53.00 EUR
Change Today 0.00 / 0.00%
Volume 0.0
ABBV On Other Exchanges
Symbol
Exchange
New York
EN Paris
Mexico
Frankfurt
As of 9:05 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for abbvie inc (ABBV)

Year over year, AbbVie Inc. has seen net income shrink from $5.3B USD to $4.1B USD despite relatively flat revenues. A key factor has been an increase in the percentage of sales devoted to income tax expense from 2.45% to 6.41%.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Restated
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues15,638.017,444.018,380.018,790.0
TOTAL REVENUES15,638.017,444.018,380.018,790.0
Cost of Goods Sold4,287.04,597.04,508.04,581.0
GROSS PROFIT11,351.012,847.013,872.014,209.0
Selling General & Admin Expenses, Total3,764.04,345.04,668.05,085.0
R&D Expenses2,369.02,500.02,582.02,840.0
OTHER OPERATING EXPENSES, TOTAL6,133.06,845.07,250.07,925.0
OPERATING INCOME5,218.06,002.06,622.06,284.0
Interest Expense-----104.0-299.0
Interest and Investment Income28.020.020.021.0
NET INTEREST EXPENSE28.020.0-84.0-278.0
Currency Exchange Gains (Loss)30.030.0-17.0-55.0
Other Non-Operating Income (Expenses)61.054.090.012.0
EBT, EXCLUDING UNUSUAL ITEMS5,337.06,106.06,611.05,963.0
Merger & Restructuring Charges-188.0-163.0-191.0-54.0
Gain (Loss) on Sale of Investments-----52.0--
Other Unusual Items, Total-313.0-2,275.0-643.0-577.0
In Process R&D Expenses-313.0-673.0-288.0-338.0
Legal Settlements---1,500.0-100.0--
Other Unusual Items---56.0-242.0-239.0
EBT, INCLUDING UNUSUAL ITEMS4,836.03,668.05,725.05,332.0
Income Tax Expense658.0235.0450.01,204.0
Earnings from Continuing Operations4,178.03,433.05,275.04,128.0
NET INCOME4,178.03,433.05,275.04,128.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS4,178.03,433.05,275.04,102.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS4,178.03,433.05,275.04,102.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABBV:FP €53.00 EUR 0.00

ABBV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amgen Inc $163.91 USD +1.67
AstraZeneca PLC 4,660 GBp -16.00
Bristol-Myers Squibb Co $58.57 USD +0.05
Eli Lilly & Co $67.25 USD +0.40
Novo Nordisk A/S kr267.00 DKK +0.50
View Industry Companies
 

Industry Analysis

ABBV

Industry Average

Valuation ABBV Industry Range
Price/Earnings 29.6x
Price/Sales 5.5x
Price/Book 23.2x
Price/Cash Flow 29.1x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBVIE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.